Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting

    NEXT STORY
    ADMA Biologics Announces Pricing of Public Offering of Common Stock
    PREV STORY
    Terveystalo’s network of occupational health services to expand: Terveystalo to acquire Työsyke Oy in Kanta-Häme
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ERYTECH kündigt Veröffentlichung seiner Phase-2b-Studie zu Eryaspase bei metastatischem Bauchspeicheldrüsenkrebs im European Journal of Cancer an

    author_avatar
    NASDAQ Market News

    Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)

    author_avatar
    NASDAQ Market News

    Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019

    author_avatar
    NASDAQ Market News